Page 103 - product-manual
P. 103

TM/MC  TM/MC
             REFERENCES (cont’d)








        López Galera RM, Ribera Pascuet E, Esteban Mur JI, et al. (2008). Interaction between cat’s claw and protease inhibitors atazanavir, ritonavir and saquinavir. European
        Journal of Clinical Pharmacology. 64:1235-6.

        Luo X, Yang K, Sun M. (2009). Immunoregulatory effect of Huangqi Fuzhengtang on immunosuppressive mice (in Chinese). Zhong Nan Da Xue Xue Bao Yi Xue Ban. 34:555-
        8.

        Manjrekar PN, Jolly CI, Narayanan S. (2000). Comparative studies of the immunomodulatory activity of Tinospora cordifolia and Tinospora sinensis. Fitoterapia. 71:254-7.

        McRae S. (1996). Elevated serum digoxin levels in a patient taking digoxin and Siberian ginseng. CMAJ. 155(3):293-5.

        Miller LG. (1998). Herbal medicinals: selected clinical considerations focusing on known or potential drug-herb interactions. Archives of Internal Medicine. 158:2200-2211.

        Mills S, Bone K. (2000). “Siberian Ginseng” Principles and Practice of Phytotherapy. Edinburgh (Scotland), Churchill Livingstone. 534-541.

        Misra DS, Maiti R, Ghosh D. (2009). Protection of swimming-induced oxidative stress in some vital organs by the treatment of composite extract of Withania somnifera,
        Ocimum sanctum and Zingiber officinalis in male rat. African Journal of Traditional, Complementary, and Alternative Medicine. 6:534-43.

        Nair PK, Melnick SJ, Ramachandran R, et al. (2006). Mechanism of macrophage activation by (1,4)-alpha-D-glucan isolated from Tinospora cordifolia. International
        Immunopharmacology. 6:1815-24.

        Panossian A, Wagner H. (2005). Stimulating effect of adaptogens: an overview with particular reference to their efficacy following single dose administration.
        Phytotherapy Research. 19:819-38.

        Pellati F, Benvenuti S, Margo L. et al. (2004). Analysis of phenolic compounds and radical scavenging activity of Echinacea. Journal of
        Pharmaceutical and Biomedical Analysis. 35:289-301.

        Perri D, Dugoua JJ, Mills E, Koren G. (2006). Safety and efficacy of Echinacea (Echinacea angustifolia, E. purpurea and E. pallida) during pregnancy and lactation. Canadian
        Journal of Pharmacology. 13:e262-e267.

        Prakash P, Gupta N. (2005). Therapeutic uses of Ocimum sanctum Linn (Tulsi) with a note on eugenol and its pharmacological actions: a short review. Indian Journal of
        Physiology and Pharmacology. 49:125-31.

        Rahman S, Islam R, Kamruzzaman M, et al. (2011). Ocimum sanctum L.: a review of phytochemical and pharmacological profile. American Journal of Drug Discovery and
        Development. DOI: 10.3923/ajdd.2011.

        Rajasankar S, Manivasagam T, Surendran S. (2009). Ashwagandha leaf extract: a potential agent in treating oxidative damage and physiological abnormalities seen in a
        mouse model of Parkinson’s disease. Neuroscience Letters. 454:11-5.

        Reichling J, Fitzi J, Fürst-Jucker J, et al. (2003). Echinacea powder: treatment for canine chronic and seasonal upper respiratory tract infections. Schweizer Archiv für
        Tierheilkunde. 145:223-31.

        Reinhard KH. (1999). Uncaria tomentosa (Willd.) D.C.: cat’s claw, uña de gato, or savéntaro. Journal of Alternative and Complementary Medicine. 5:143-51.

        Rittenhouse JR, Lui PD, Lau BH. (1991). Chinese medicinal herbs reverse macrophage suppression induced by urological tumors. The Journal of Urology. 146:486-90.

        Sanodiya BS, Thakur GS, Baghel RK, et al. (2009). Ganoderma lucidum: a potent pharmacological macrofungus. Current Pharmaceutical
        Biotechnology. 10:717-42.

        Scott GN, Elmer GW. (2002). Update on natural product – drug interactions. American Journal of Health-System Pharmacy. 59:339-47.






        12 |   Immunine -VM TM
   98   99   100   101   102   103   104   105   106   107   108